Sartorius to acquire Albumedix
Sartorius will acquire all outstanding shares of Albumedix Ltd. for approximately £415 million
10-Aug-2022 -
The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions. Recombinant human albumin is an ...
acquisitions
albumin
cell culture media
+1